Vaccines production: FEC approves joint venture with Serum Institute of India

AVAT launches new scheme for Covid-19 vaccine compensation

AVAT has established a No-Fault Compensation Scheme for COVID-19 vaccines in participating countries

The Federal Executive Council ( FEC) on Wednesday approved a joint venture partnership arrangement between Bio vaccine Nigeria limited and Serum Institute of India for the production of vaccines in Nigeria. The Minister of Health, Osagie Ehanire revealed this while briefing State House Journalist

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```